Riskpilot← Back to searchSign inGet full accessDEMANT NORWAY AS
ASActiveOrg 818885032Hegdehaugsveien 31, 0352 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 197336 employeeswww.oticon.no
Revenue 2024
NOK 218,1M
+14% vs 2023
EBITDA margin
4.4%
+89% vs 2023
Equity ratio
29.6%
Financial strength
Net profit 2024
NOK 7,3M
+80% vs 2023
| Revenue | NOK 218,1M | +14% |
| EBITDA | NOK 9,5M | +89% |
| Net profit | NOK 7,3M | +80% |
| Total assets | NOK 182M | +16% |
| Equity | NOK 53,9M | +16% |
| Employees | 36 | — |
Legal name
DEMANT NORWAY AS
Org number
818885032
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
2. januar 1973
Share capital
—
Employees
36 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder alene.
Address
Hegdehaugsveien 31, 0352 Oslo
Website
www.oticon.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 152 073 | 162 163 | 156 750 | 190 942 | 218 082 |
| Staff expenses | −18 895 | −21 287 | −22 137 | −25 870 | −30 295 |
| EBITDA | 7 011 | 4 604 | 4 199 | 5 028 | 9 525 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 7 011 | 4 604 | 4 199 | 5 028 | 9 525 |
| Net financials | 9 | −42 | 29 | 251 | 312 |
| Profit before tax | 7 020 | 4 562 | 4 228 | 5 279 | 9 836 |
| Tax | 1 573 | 1 030 | 1 450 | 1 188 | 2 490 |
| Net profit | 5 447 | 3 531 | 2 778 | 4 091 | 7 346 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 117 678 | 117 166 | 114 159 | 157 263 | 182 006 |
| Equity | 34 830 | 38 362 | 42 497 | 46 588 | 53 934 |
| Long-term debt | 1 434 | 1 555 | 1 442 | 1 587 | 500 |
| Short-term debt | 81 414 | 77 249 | 70 219 | 109 087 | 127 572 |
| Total debt | 82 848 | 78 804 | 71 662 | 110 675 | 128 072 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20202024
Equity ratio
29.6%
This company
38.2%
Market median
-23% vs market
20202024
Return on equity
13.6%
This company
18.4%
Market median
+26% vs market
20202024
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
20202024
Asset turnover
1.20×
This company
1.12×
Market median
+7% vs market
20202024
Debt / equity
2.37×
This company
0.62×
Market median
-282% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KW Chief Executive Officer | Chief Executive Officer | 2026 |
JR Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
LM Chief Executive Officer | Chief Executive Officer | 2001 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
William Demant Holding As | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DEMANT NORWAY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Martin Osen | Chief Executive Officer | 0 companies |
| Karen Wibling Solgård | Chief Executive Officer | 0 companies |
| Janne Renate Aamodt Stang | Chief Executive Officer | 0 companies |
| Søren Nielsen | Chairman | 0 companies |
| Rene Schneider | Board of Directors | 0 companies |